Dapsone Rx and athletes: does it show up on drug tests?

Last updated 2026-07-27

Is dapsone banned in sports (WADA or USADA)?

No. Dapsone, in either its topical or oral form, does not appear on the World Anti-Doping Agency's Prohibited List ^[1]. WADA publishes an updated list every year (the 2024 and 2025 versions are both posted on wada-ama.org), organized into categories like anabolic agents, hormones, diuretics, stimulants, and so on. Dapsone isn't in any of those categories. That matters for athletes because a lot of banned substances hide in unexpected places, and topical acne treatments are a category athletes worry about (some acne drugs, like certain hormonal treatments, can raise flags). Dapsone gel or oral dapsone is not one of those cases. USADA, which handles testing for US Olympic and Paralympic athletes, follows the same WADA list, so the same answer applies there ^[2]. If you're an NCAA athlete, the NCAA also publishes its own banned drug classes, and dapsone is not on that list either. One caveat: "not banned" doesn't mean "never worth checking." If you're a tested athlete, run any new prescription, dapsone or otherwise, through Global DRO (globaldro.com), a free lookup tool built specifically for this. It takes under a minute and it's the honest way to confirm status rather than relying on an article, even this one.

Will topical dapsone (Aczone) cause a positive drug test?

No. Aczone (dapsone gel 5% and 7.5%) is FDA-approved for acne vulgaris, applied directly to the skin, and absorbed into the bloodstream only in small amounts ^[3]. It's not a stimulant, steroid, diuretic, or masking agent, the categories drug testing panels actually screen for. Standard sports drug tests, whether urine panels for anabolic steroids or the biological passport program WADA uses for blood doping, are not built to detect dapsone. It isn't a substance those panels are designed to catch in the first place, because it isn't prohibited. Worth separating from doping tests: workplace and pre-employment drug screens (the 5-panel or 10-panel tests that check for THC, opioids, cocaine, amphetamines, PCP) also do not test for dapsone. Different technology, different target list, same answer. It's not going to trigger anything. If you use Aczone for acne and you're also a tested athlete, the practical move is to keep your prescription documentation handy (a photo of the label, the pharmacy receipt) in case a sample collector or your team physician asks what medications you're on. That's a routine disclosure step for any prescription drug, not a defense against a positive, because there's no positive to defend against here.

What's the difference between topical and oral dapsone (and why does it matter for testing)?

Topical dapsone is a gel you rub on your face. Oral dapsone is a systemic antibiotic pill with a much longer list of risks and a much smaller list of approved uses. Mixing these up is the single most common and most dangerous confusion in dapsone research online. Topical dapsone (Aczone) is FDA-approved specifically for acne vulgaris in patients 9 years and older ^[3]. It's a low-dose, low-absorption product. Clinical trials supporting its approval showed modest but real improvement in inflammatory acne lesions compared to vehicle gel, with headache and mild dryness as the most common side effects ^[3]. Oral dapsone is a sulfone-class antibiotic, FDA-approved for leprosy (Hansen's disease) and dermatitis herpetiformis, and used off-label for conditions like severe cutaneous lupus, bullous pemphigoid, and some other autoimmune-adjacent skin diseases ^[4]. It is not an acne drug. Nobody's dermatologist should be starting oral dapsone as a first-line acne treatment; that's not what it's for and the risk profile doesn't justify it. The reason this distinction matters beyond safety: an athlete taking topical Aczone has essentially nothing to think about regarding drug testing. An athlete (or anyone) on oral dapsone is dealing with a real systemic drug that requires blood monitoring, G6PD screening, and physician supervision, described in the next section. For dosing specifics on the oral form, see Dapsone Rx dosage and the Dapsone Rx dosage calculator.

Why does oral dapsone require a G6PD test before you start it?

Because dapsone oxidizes hemoglobin and red blood cells, and people with G6PD (glucose-6-phosphate dehydrogenase) deficiency lack the enzyme protection that normally limits that damage. In G6PD-deficient patients, oral dapsone can trigger severe hemolytic anemia, a rapid breakdown of red blood cells that can land someone in the hospital. The FDA label for dapsone tablets states that patients should be tested for G6PD deficiency before starting therapy, and that hemolysis is dose-related and occurs to some degree in most patients, with the effect being more pronounced in those who are G6PD deficient ^[4]. This is not a rare theoretical warning. It's a standard pre-treatment lab test, similar in spirit to checking kidney function before starting certain other drugs. G6PD deficiency is an X-linked genetic condition. It's more common in people of African, Mediterranean, Middle Eastern, and Southeast Asian ancestry, and the CDC notes it is one of the most common enzyme deficiencies worldwide, with estimates in the range of roughly 400 million people affected globally ^[5]. Most people with G6PD deficiency have no idea they have it until a drug or illness triggers a hemolytic episode. A simple blood test (checking G6PD enzyme activity) before starting oral dapsone is standard of care and takes a few days for results. Skipping it is the kind of shortcut that turns a manageable prescription into an ER visit.

What other risks does oral dapsone carry that topical doesn't?

Oral dapsone has a real side effect list that topical dapsone simply doesn't share, because the systemic exposure is orders of magnitude different. Four risks show up repeatedly in the prescribing information and case literature: Hemolytic anemia. As above, dose-related, worse in G6PD deficiency, but it happens to some extent in most people on oral dapsone, per the FDA label ^[4]. Methemoglobinemia. Dapsone can convert hemoglobin into methemoglobin, a form that can't carry oxygen properly, causing symptoms from mild fatigue and shortness of breath to (rarely) more severe cyanosis at high levels. It's a known, monitored side effect of oral therapy ^[4]. Dapsone hypersensitivity syndrome. A rare but serious reaction, usually appearing 2 to 6 weeks after starting oral dapsone, involving fever, rash, and organ involvement (commonly liver). It carries a real mortality risk if not caught early, and it's part of why oral dapsone requires physician follow-up in the first weeks of treatment ^[4]. Agranulocytosis. A drop in white blood cells that impairs infection-fighting ability, listed as a rare but serious adverse effect in the FDA label, monitored with periodic blood counts during oral therapy ^[4]. None of these four risks are meaningfully associated with topical Aczone at approved doses, because the systemic drug level from a topical gel applied to the face is a small fraction of what an oral dose delivers. That's the whole reason the FDA approved dapsone gel as a low-risk topical rather than requiring the monitoring oral dapsone needs.

Does the FDA approve oral dapsone for acne at all?

No. The FDA-approved indications for oral dapsone tablets are leprosy (all forms, including lepromatous, tuberculoid, and borderline) and dermatitis herpetiformis ^[4]. Acne is not on that list, in any form or dose. Dermatologists sometimes use oral dapsone off-label for severe inflammatory skin conditions that don't respond to standard therapy, but that's a specialist decision made with lab monitoring in place, not a self-directed choice for garden-variety acne. If a prescriber suggests oral dapsone for acne specifically, it's worth asking directly why topical options (dapsone gel, retinoids, benzoyl peroxide, oral antibiotics like doxycycline, or isotretinoin for severe cases) aren't being tried first. The acne evidence base is built around the topical gel, not the pill. The key trials that got Aczone approved, and the label indication itself, are specific to gel formulations applied to the skin ^[3]. Reaching for the oral form for a cosmetic-adjacent condition like acne isn't supported by the drug's approval history and isn't something a well-informed patient should accept without a clear clinical reason.

Can dapsone interact with other medications athletes commonly use?

Yes, and this is a real safety question separate from drug testing. Oral dapsone has documented interactions worth knowing about, though this list is not exhaustive and any interaction check should go through a pharmacist or physician who has your full medication list. Trimethoprim (found in the combination antibiotic trimethoprim-sulfamethoxazole, brand name Bactrim) increases blood levels of both drugs and raises the risk of methemoglobinemia when combined with dapsone ^[4]. Rifampin, an antibiotic sometimes used for stubborn infections, can significantly lower dapsone blood levels by speeding up its metabolism, reducing effectiveness ^[4]. Drugs and supplements that themselves cause oxidative stress on red blood cells (certain other sulfa drugs, in some cases high-dose vitamin C, though data there is thinner) can compound the hemolysis risk in anyone, and especially in G6PD-deficient patients. Athletes taking common supplements or over-the-counter NSAIDs for training-related pain shouldn't assume anything is automatically safe to combine with oral dapsone. This is exactly the kind of question to bring to the prescribing physician, not to guess about based on a supplement label.

How is oral dapsone dosed, and does that affect risk?

Oral dapsone dosing varies a lot by indication. For dermatitis herpetiformis, the FDA label describes a typical starting range as low as 50 mg per day with adjustment based on response, while leprosy regimens (often combined with other antibiotics like rifampin) follow multidrug therapy protocols ^[4]. Off-label dermatologic uses are dosed individually by the prescriber based on the condition and patient factors. Higher doses generally track with higher hemolysis and methemoglobinemia risk, which is part of why routine blood work (CBC, methemoglobin level checks) happens on a schedule during treatment, especially in the first few months. This is not a "start high and see what happens" drug. For readers managing an actual oral dapsone prescription under physician supervision, our dosing hub covers this in more depth: see Dapsone Rx dosage, the Dapsone Rx dosage calculator, guidance on how to reconstitute Dapsone Rx if you're working with an injectable or compounded form, Dapsone Rx how to inject, Dapsone Rx injection sites, and Dapsone Rx cycle length for how long a given course typically runs. None of that replaces your prescriber's specific plan. It's background reading to bring better questions to that appointment.

Where does topical dapsone fit for an athlete who just wants to treat acne safely?

For most people, including athletes under drug testing, topical dapsone (Aczone) is the low-risk, well-studied option, and it's not a testing concern at all. The clinical trial data behind its FDA approval showed meaningful reduction in inflammatory acne lesions versus vehicle gel over 12 weeks, with the most common side effects being mild: oiliness, dryness, redness at the application site ^[3]. If you're getting a prescription for acne and want it handled with actual physician review rather than guesswork, Dapsone Rx offers a provider-reviewed path to topical dapsone, with prescriptions filled through a licensed pharmacy partner. That's a reasonable route for the topical form specifically. It is not, and shouldn't be treated as, a pathway to oral dapsone for acne, because oral dapsone isn't an appropriate acne treatment in the first place and needs the G6PD screening and monitoring described above. The short version: if acne is the problem, the topical gel is almost certainly the answer, and it carries essentially no drug-testing or systemic-risk baggage. If a prescriber is talking about oral dapsone for acne, that's worth a second opinion before it's worth a prescription.

Frequently asked questions

Is dapsone on the WADA banned substances list?

No. Neither topical nor oral dapsone appears on the current WADA Prohibited List ^[1]. WADA updates this list yearly, and dapsone has not been included in recent versions. Athletes can verify current status anytime using the free Global DRO lookup tool (globaldro.com), which cross-references specific drug names against the current WADA list.

Will Aczone (topical dapsone) show up on a workplace drug test?

No. Standard 5-panel and 10-panel workplace drug tests screen for substances like THC, opioids, amphetamines, cocaine, and PCP. Topical dapsone gel is not on any standard screening panel and isn't chemically related to the substances those tests detect, so it will not cause a positive result.

Do I need a G6PD test before using topical dapsone for acne?

Generally no, because absorption from the topical gel into the bloodstream is minimal at approved doses, per the FDA label for Aczone ^[3]. G6PD testing is specifically recommended before starting oral dapsone, since that form carries meaningful hemolysis risk. If you have known G6PD deficiency, mention it to your prescriber regardless of which form you're considering.

What is dapsone hypersensitivity syndrome?

It's a rare but serious reaction to oral dapsone, usually starting 2 to 6 weeks after treatment begins, with fever, skin rash, and organ involvement (often the liver). It's listed as a serious adverse reaction in the FDA prescribing information for dapsone tablets ^[4] and is one reason oral dapsone requires early, close physician follow-up.

Can oral dapsone cause anemia?

Yes. The FDA label states that hemolysis (red blood cell breakdown) is dose-related and occurs to some degree in most patients taking oral dapsone, and is more severe in people with G6PD deficiency ^[4]. This is a core reason for pre-treatment G6PD screening and periodic blood monitoring during therapy.

Is oral dapsone FDA-approved for acne?

No. Oral dapsone's FDA-approved uses are leprosy and dermatitis herpetiformis ^[4]. It is sometimes used off-label by dermatologists for other serious skin conditions, but it is not an approved or standard treatment for acne. Topical dapsone gel (Aczone) is the FDA-approved acne formulation ^[3].

What's the difference between dapsone gel and dapsone tablets?

Dapsone gel (Aczone, 5% and 7.5%) is applied to the skin for acne and has minimal systemic absorption. Dapsone tablets are swallowed, distribute throughout the body, and are approved for leprosy and dermatitis herpetiformis. The tablet form carries real risks (hemolysis, methemoglobinemia, agranulocytosis) that the gel does not meaningfully share at approved doses ^[3][4].

Does the NCAA ban dapsone?

Dapsone does not appear on the NCAA's list of banned drug classes. The NCAA bans categories like stimulants, anabolic agents, diuretics/masking agents, and certain hormone and metabolic modulators; dapsone, topical or oral, falls outside all of those categories.

Can dapsone interact with antibiotics athletes might already be taking?

Yes, notably trimethoprim (in Bactrim), which can raise dapsone levels and increase methemoglobinemia risk, and rifampin, which can lower dapsone's effectiveness by speeding its breakdown ^[4]. Anyone on oral dapsone should give their full medication and supplement list to their prescriber before adding anything new.

How common is G6PD deficiency, and how would I know if I have it?

G6PD deficiency is estimated to affect roughly 400 million people worldwide, and the CDC notes it is more common in people of African, Mediterranean, Middle Eastern, and Southeast Asian descent ^[5]. Most people don't know they have it until a triggering drug or illness causes symptoms, which is exactly why a simple blood test is done before starting oral dapsone.

Should I ask my doctor for oral dapsone if topical treatment isn't working for my acne?

Probably not as a next step. Oral dapsone isn't FDA-approved for acne and carries risks (hemolysis, methemoglobinemia, hypersensitivity syndrome) that aren't justified for a condition with safer escalation options like oral antibiotics, hormonal therapy, or isotretinoin. Ask about those before oral dapsone enters the conversation.

Where can I check if a specific medication is banned in my sport?

Use Global DRO (globaldro.com), a free, searchable database built jointly by anti-doping agencies including USADA, that tells you the current status of a specific drug name and formulation under the WADA Prohibited List. It's the fastest reliable check, faster and more current than any article.

Sources

1. World Anti-Doping Agency, Prohibited List: Dapsone does not appear on WADA's Prohibited List
2. USADA, Prohibited List overview: USADA follows the WADA Prohibited List for US Olympic/Paralympic testing
3. FDA, Aczone (dapsone gel) prescribing information, DailyMed: Aczone is FDA-approved for acne vulgaris, low systemic absorption, common side effects
4. FDA, Dapsone Tablets USP 25 mg and 100 mg prescribing information, DailyMed: Oral dapsone indications (leprosy, dermatitis herpetiformis), G6PD testing recommendation, hemolysis, methemoglobinemia, hypersensitivity syndrome, agranulocytosis, drug interactions with trimethoprim and rifampin
5. CDC, Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD): G6PD deficiency prevalence and higher frequency in certain ancestral populations